glp-1 obesity drug news today oct 23 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ GLP-1 Agonists Weight Loss Drugs
Description
GLP-1 agonists have demonstrated safety and efficacy in clinical trials for weight loss, but individual safety depends on medical history, dosing protocol, and ongoing provider oversight
Obesity and type 2 diabetes remain critical global health challenges, with rising prevalence demanding innovative treatment approaches
Get the details.
Infused with Mulberry Leaf Extract and sweetened with Monk Fruit.
Learn their history, when they were introduced, and why these medications are widely used today.
